ICD-10 Coding for Squamous Cell Carcinoma In Situ(D04.0, C44.0, C44.3)
SaveLearn about ICD-10 coding for squamous cell carcinoma in situ, including site-specific codes, documentation requirements, and common pitfalls.
Complete code families applicable to Squamous Cell Carcinoma In Situ
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D04.0 | Carcinoma in situ of skin of lip | Use when biopsy confirms SCCIS on the lip. |
|
| D04.3 | Carcinoma in situ of skin of other parts of face | Use when biopsy confirms SCCIS on the face, specifying the exact location. |
|
| D04.9 | Carcinoma in situ of skin, unspecified | Use when the site of SCCIS is not specified in the documentation. |
|
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Squamous Cell Carcinoma In Situ.
Omitting 'in situ' in documentation
Impact
Clinical: Leads to incorrect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims or incorrect billing.
Mitigation
Educate providers on documentation requirements., Implement documentation audits.
Coding as C44.XX without 'in situ' specification
Impact
Reimbursement: Incorrect coding can lead to denied claims or incorrect reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation
Query provider to confirm 'in situ' status and use D04.XX if confirmed.
Site-specific documentation
Impact
Failure to document specific site can lead to incorrect coding.
Mitigation
Implement documentation audits and provider education.